Navigation Links
NC Biomanufacturers Supply Defense for World vs. Flu
Date:4/29/2009

Huge GSK, Novartis, Merck plants help define state's economic successes

RESEARCH TRIANGLE PARK, N.C., April 29 /PRNewswire-USNewswire/ -- The global fight against swine flu is shining a spotlight on North Carolina's long-term commitment to biomanufacturing.

Global pharmaceutical giant GlaxoSmithKline, with North American headquarters in Research Triangle Park, is one of the world's two key manufacturers of antiviral flu treatments. GSK makes Relenza at its plant in Zebulon, about 25 miles east of its headquarters campus.

GSK and Swiss drug company Roche, which makes Tamiflu, have notified the World Health Organization that this new strain of the swine-flu virus seems to respond to their medicines.

"When we're called upon to tackle these kinds of disease outbreaks, North Carolina's excellent base of medical research and pharmaceutical manufacturing puts us among global leaders," said E. Norris Tolson, president and CEO of the North Carolina Biotechnology Center.

North Carolina has invested $1.2 billion in steady bioscience growth during the past decade, said Tolson. "Some states aren't so interested in manufacturing. But at times like these, it becomes clear why these science-driven factories are so crucial."

Hundreds of workers at GSK's Zebulon factory have made medicines to supply the world for more than two decades. Meanwhile, Novartis has a flu-vaccine plant under construction at the edge of Holly Springs, about 20 miles southwest of Raleigh.

Read the full story online.

The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.

Contact: Chris Brodie, vice president of corporate communications, North Carolina Biotechnology Center, chris_brodie@ncbiotech.org or 919-541-9366. Visit the Biotechnology Center's Web site at www.ncbiotech.org.


'/>"/>
SOURCE North Carolina Biotechnology Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hospira Names Brian Meadows Supply Chain Chief
2. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
3. Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
4. New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel
5. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
6. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology
7. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
8. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
9. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
10. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
11. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... of the QB3@953 life sciences incubator to ... health. The shared laboratory space at QB3@953 was created ... a key obstacle for many early stage organizations - ... of the sponsorship, Amgen launched two "Amgen Golden Ticket" ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
Breaking Biology News(10 mins):